secwatch / observer
8-K filed March 13, 2023, 7:59 PM ET ticker GBCS CIK 0000727346
leadership confidence high sentiment neutral materiality 0.60

CFO Christine Lucus resigns effective April 5, 2023; CEO Lance Baller interim PFO

SELECTIS HEALTH, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Christine Lucus

Chief Financial Officer
GBCS · SELECTIS HEALTH, INC.
Effective
2023-04-05
Filed
March 13, 2023, 7:59 PM ET
On March 6, 2023, Christine Lucus tendered her resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), effective April 5, 2023.
Appointed (interim)

Lance Baller

principal financial officer
GBCS · SELECTIS HEALTH, INC.
Effective
2023-04-05
Filed
March 13, 2023, 7:59 PM ET
Lance Baller, our current CEO, will serve as the Company’s principal financial officer until we identify a permanent CFO.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christine Lucus resigned as Chief Financial Officer at SELECTIS HEALTH, INC..

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
On March 6, 2023, Christine Lucus tendered her resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), effective April 5, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Lance Baller was appointed as principal financial officer at SELECTIS HEALTH, INC..

Action
will serve as
Role
principal financial officer
Exact text from the filing
Lance Baller, our current CEO, will serve as the Company’s principal financial officer until we identify a permanent CFO.
View on SEC.gov

SELECTIS HEALTH, INC. filing history →

Source: SEC EDGAR
accession 0001493152-23-007424
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.